Diversity Management, News and Updates
Originally published on sanofi.com. Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19 Companies to combine innovative technologies to develop an adjuvanted COVID-19 vaccine Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to be available in the second…
Johnson & Johnson announced the launching of an eight-week-long educational live series hosted by producer and journalist Lisa Ling. The series will address the COVID-19 crisis and highlight global efforts to develop a vaccine and treatment options. Beginning April 14, every Tuesday, Johnson & Johnson will broadcast the series live…
Johnson & Johnson (A DiversityInc Hall of Fame Company) announced it has a lead candidate for a potential vaccine for COVID-19, the pandemic sweeping the world and killing thousands. “The world is facing an urgent public health crisis and we are committed to doing our part to make a COVID-19 vaccine available…
Originally published on Sanofi.com. The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older. Fluzone® High-Dose (Influenza Vaccine) was approved by the FDA in 2009 as a trivalent influenza vaccine, including two…